INTRODUCTION {#s1}
============

The TGF-β signaling pathway is an essential regulator of cellular proliferation, differentiation, apoptosis, extracellular matrix remodeling in the cell, and is involved in angiogenesis and inflammation \[[@R1], [@R2]\]. Components of this pathway have been associated with colorectal cancer risk and survival \[[@R3]--[@R8]\]. There are several components of the TGF-β signaling pathway. Smads are key intracellular mediators of the transcriptional responses to TGF-β \[[@R9]\]. Bone morphogenetic proteins (BMP), trigger a Smad-signaling cascade that is linked to reduced cell proliferation and cellular growth kinetics of glioblastomas \[[@R10], [@R11]\]. The Runt-related transcription factors (RUNX), *RUNX1*, *RUNX2*, and *RUNX3* \[[@R12]\] are involved in signaling cascades mediated by TGF-β and BMP \[[@R13]--[@R16]\]. All three of the RUNX genes have been shown to bind Smads \[[@R17]--[@R19]\]. Studies in *RUNX3* knockout mice have shown defects in apoptotic response to TGF-β; *RUNX2* transgenic mice were hypersensitive to TGF-β in one study \[[@R14]\]. Mitogen-activated protein kinase 1 (MAPK1) activates RUNX2 \[[@R20]\] and is involved in the TGF-β-signaling pathway through its role in Smad signaling \[[@R21], [@R22]\]. Eukaryotic translation initiation factor 4E (eIF4E) is a translational regulator; expression of eIF4E in human colon cancer cells promotes the TGFβ stimulation of adhesion molecules \[[@R23]\]. Other genes, such as nuclear factor kappa B1 (NFκB1), mammalian target of rapamycin (mTOR), and phosphatase tensin homolog deleted on chromosome 10 (PTEN), are major regulators of inflammation, are associated with colorectal cancer, and influence the TGF-B signaling pathway \[[@R24]--[@R26]\].

The TGF-β signaling pathway has been shown to suppress growth and tumorigenicity in a normal cellular environment; but, in neoplastic cells, its role converts to the promotion of invasion and metastasis \[[@R27]\]. It has recently been hypothesized that miRNAs may be intermediaries in a TGFβ-miRNA pathway that both mediates cell growth and promotes invasive behavior \[[@R28]\]. Some studies have linked miRNAs and the TGF-β signaling pathway. For instance miR-181a has its expression upregulated by TGFβ, which in turn promotes breast cancer metastasis \[[@R28], [@R29]\]. Other studies have shown that TGFβ activates AKT kinase through mechanisms involving miRNAs, and that TGFβ-signaling may be involved in the control of miRNA biogenesis \[[@R30], [@R31]\].

In this paper, we test the hypothesis that genetic variation in the TGF-β signaling pathway is associated with miRNA expression level. We use data from a large study of colorectal cancer cases. We focus on genetic variants in 21 genes in the TGF-β signaling pathway that we have previously shown to be associated with either colon or rectal cancer risk or survival after diagnosis. Our ability to show that these genetic variants alter miRNA expression adds support to the importance of these SNPs in cancer risk.

RESULTS {#s2}
=======

The majority of cases for both colon and rectal cancer studies were male (Table [1](#T1){ref-type="table"}). The mean age at diagnosis was slightly older for those individuals enrolled in the colon cancer study compared to those enrolled in the rectal cancer study. Over 80% of the study population was non-Hispanic white. The majority of cases were diagnosed at either an AJCC stage 1 or stage 2.

###### Description of study population

                         Colon   Rectal          
  ---------------------- ------- -------- ------ ------
  Center                                         
   Kaiser                509     73.9     302    60.5
   Utah                  180     26.1     197    39.5
  Sex                                            
   Male                  383     55.6     296    59.3
   Female                306     44.4     203    40.7
  Race                                           
   White, non-Hispanic   594     86.2     400    80.2
   Hispanic              47      6.8      46     9.2
   Black, non-Hispanic   46      6.7      18     3.6
   Other/Unknown         2       0.3      35     7.0
  Vital Status^1^                                
   Dead                  279     40.6     184    36.9
   Alive                 409     59.4     315    63.1
  AJCC Stage^2^                                  
   1                     169     24.8     227    46.0
   2                     221     32.4     94     19.0
   3                     226     33.1     142    28.7
   4                     66      9.7      31     6.3
                         Mean    SD       Mean   SD
  Age                    65.3    9.1      61.8   11.1
  Survival Months        69.3    32.7     67.6   27.2

^1^ Vital Status missing for one individual.

^2^ AJCC stage unknown for 12 people.

MiRNA expression level differed across genotypes of seven SNPs, *eIF4E* rs12498533, *NFκB1* rs230510, *TGFB1* rs4803455, *TGFBR1* rs1571590 and rs6478974, *SMAD3* rs3743343, and *RUNX1* rs8134179 in normal colorectal mucosa (Table [2](#T2){ref-type="table"}). All but four miRNAs, miR-4324, miR-4655-3p, miR-3663-3p, and miR-1539 that were significantly different by both *TGFBR1* rs1571590 and *TGFBR1* rs6478974 when considering an FDR of \<0.09 ([Supplementary Table 1](#SD2){ref-type="supplementary-material"} for all associations). However, the majority of miRNAs associated with rs6478974 were downregulated for the variant allele, while for rs1571590 the miRNAs were equally up and downregulated for the variant allele. For *EIF4E* rs12498533, *NFKB1* rs230510, *SMAD3* rs3743343, *TGFB1* rs4803455, all miRNAs were downregulated in the presence of the variant allele. However, for *RUNX1* rs8134179 all of the miRNAs were upregulated in the variant allele.

###### Associations between TGFB-pathway SNPs and miRNA differential expression in colorectal tissue

  miRNA                         Mean             Mean            P-values   FDR adjusted P   Direction
  ----------------------------- ---------------- --------------- ---------- ---------------- ---------------
  ***EIF4E*** (rs12498533)      AA (N=342)       AC/CC (N=798)                               
  hsa-miR-221-3p                3.21             2.25            \<.0001    0.0820           Downregulated
  ***TGFBR1*** (rs1571590)^1^   AA (N=738)       AG/GG (N=372)                               
  hsa-miR-100-5p                7.83             6.06            \<.0001    0.0373           Downregulated
  hsa-miR-130a-3p               3.20             2.26            0.0004     0.0373           Downregulated
  hsa-miR-143-3p                7.23             5.89            0.0004     0.0373           Downregulated
  hsa-miR-19b-3p                8.53             6.67            0.0003     0.0373           Downregulated
  hsa-miR-29c-3p                15.56            13.19           0.0005     0.0373           Downregulated
  hsa-miR-3666                  19.31            20.74           \<.0001    0.0373           Upregulated
  hsa-miR-4324                  1.30             0.98            0.0002     0.0373           Downregulated
  hsa-miR-4655-3p               22.54            24.35           0.0005     0.0373           Upregulated
  hsa-miR-4659a-3p              27.57            29.81           0.0003     0.0373           Upregulated
  hsa-miR-5003-3p               18.59            20.12           0.0005     0.0373           Upregulated
  hsa-miR-6500-5p               18.18            19.53           0.0005     0.0373           Upregulated
  hsa-miR-662                   41.11            43.73           0.0006     0.0410           Upregulated
  hsa-miR-140-3p                7.16             6.09            0.0008     0.0492           Downregulated
  hsa-miR-26a-5p                86.12            75.56           0.0009     0.0492           Downregulated
  hsa-miR-4294                  21.48            22.41           0.0009     0.0492           Upregulated
  ***NFKB1*** (rs230510)        AA (N=387)       AT/TT (N=723)                               
  hsa-miR-4446-3p               16.16            13.90           \<.0001    0.0820           Downregulated
  ***SMAD3*** (rs3743343)^1^    TT/TC (N=1035)   CC (N=75)                                   
  hsa-miR-1285-3p               19.98            17.98           \<.0001    0.0410           Downregulated
  hsa-miR-3935                  16.98            14.78           \<.0001    0.0410           Downregulated
  ***TGFB1*** (rs4803455)       CC (N=275)       CA/AA (N=881)                               
  hsa-miR-146b-5p               1.48             0.92            0.0002     0.0820           Downregulated
  hsa-miR-3609                  1.68             1.20            \<.0001    0.0820           Downregulated
  ***TGFBR1*** (rs6478974)^1^   TT (N=359)       TA/AA (N=750)                               
  hsa-miR-1226-5p               54.62            51.50           0.0011     0.0355           Downregulated
  hsa-miR-151a-5p               7.57             9.03            0.0011     0.0355           Upregulated
  hsa-miR-1587                  1405.23          1292.11         0.0013     0.0355           Downregulated
  hsa-miR-199a-3p               16.51            19.29           0.0005     0.0355           Upregulated
  hsa-miR-200a-3p               18.50            20.89           0.0006     0.0355           Upregulated
  hsa-miR-20a-5p                13.21            15.67           0.0016     0.0355           Upregulated
  hsa-miR-214-3p                4.76             5.65            0.0005     0.0355           Upregulated
  hsa-miR-222-3p                8.28             8.99            0.0016     0.0355           Upregulated
  hsa-miR-22-3p                 12.78            14.57           0.0007     0.0355           Upregulated
  hsa-miR-25-3p                 8.70             10.46           0.0016     0.0355           Upregulated
  hsa-miR-26b-5p                15.33            17.83           0.0004     0.0355           Upregulated
  hsa-miR-30c-5p                7.73             9.17            0.0012     0.0355           Upregulated
  hsa-miR-3156-5p               95.91            90.85           0.0009     0.0355           Downregulated
  hsa-miR-3185                  17.99            16.77           0.0005     0.0355           Downregulated
  hsa-miR-33b-3p                19.25            15.53           0.0006     0.0355           Downregulated
  hsa-miR-3620-5p               95.85            89.60           0.0015     0.0355           Downregulated
  hsa-miR-3621                  38.13            35.90           0.0015     0.0355           Downregulated
  hsa-miR-370                   41.68            39.44           0.0002     0.0355           Downregulated
  hsa-miR-3917                  99.12            93.52           0.0005     0.0355           Downregulated
  hsa-miR-3934-3p               29.59            28.27           0.0014     0.0355           Downregulated
  hsa-miR-3937                  70.06            65.67           0.0013     0.0355           Downregulated
  hsa-miR-4253                  46.35            43.92           0.0012     0.0355           Downregulated
  hsa-miR-4294                  22.41            21.50           0.0011     0.0355           Downregulated
  hsa-miR-4535                  70.15            66.72           0.0007     0.0355           Downregulated
  hsa-miR-4655-5p               34.25            32.23           0.0013     0.0355           Downregulated
  hsa-miR-4695-5p               385.66           365.84          0.0009     0.0355           Downregulated
  hsa-miR-4726-5p               22.13            21.13           0.0015     0.0355           Downregulated
  hsa-miR-4734                  210.70           198.06          0.0013     0.0355           Downregulated
  hsa-miR-5196-5p               63.33            58.28           0.0012     0.0355           Downregulated
  hsa-miR-550a-3-5p             28.29            26.77           0.0009     0.0355           Downregulated
  hsa-miR-564                   67.17            64.76           0.0014     0.0355           Downregulated
  hsa-miR-601                   46.91            44.06           0.0010     0.0355           Downregulated
  hsa-miR-6084                  18.25            16.81           0.0012     0.0355           Downregulated
  hsa-miR-610                   25.93            24.45           0.0013     0.0355           Downregulated
  hsa-miR-6511b-5p              65.88            60.79           0.0005     0.0355           Downregulated
  hsa-miR-760                   34.80            32.70           0.0014     0.0355           Downregulated
  hsa-miR-93-5p                 10.92            12.98           \<.0001    0.0355           Upregulated
  hsa-miR-15b-5p                20.02            23.05           0.0019     0.0359           Upregulated
  hsa-miR-3187-3p               9.99             9.16            0.0021     0.0359           Downregulated
  hsa-miR-4646-5p               112.80           106.87          0.0021     0.0359           Downregulated
  hsa-miR-4738-3p               50.24            48.07           0.0020     0.0359           Downregulated
  hsa-miR-4740-5p               33.39            31.96           0.0017     0.0359           Downregulated
  hsa-miR-5189                  33.40            31.42           0.0021     0.0359           Downregulated
  hsa-miR-550b-2-5p             38.12            35.90           0.0020     0.0359           Downregulated
  hsa-miR-6124                  522.71           487.27          0.0018     0.0359           Downregulated
  hsa-miR-6165                  323.94           306.32          0.0021     0.0359           Downregulated
  hsa-miR-6500-5p               19.30            18.32           0.0019     0.0359           Downregulated
  hsa-miR-671-5p                291.07           271.09          0.0018     0.0359           Downregulated
  hsa-miR-6722-3p               103.52           97.67           0.0022     0.0368           Downregulated
  hsa-miR-196b-5p               3.53             4.76            0.0023     0.0370           Upregulated
  hsa-miR-4481                  84.65            78.48           0.0023     0.0370           Downregulated
  hsa-miR-4758-5p               131.05           120.75          0.0024     0.0378           Downregulated
  hsa-miR-1247-3p               26.28            25.11           0.0028     0.0396           Downregulated
  hsa-miR-199a-5p               6.22             7.34            0.0027     0.0396           Upregulated
  hsa-miR-345-3p                59.74            56.13           0.0026     0.0396           Downregulated
  hsa-miR-3622b-5p              38.67            36.86           0.0028     0.0396           Downregulated
  hsa-miR-451a                  25.98            32.37           0.0029     0.0396           Upregulated
  hsa-miR-5001-5p               1180.01          1096.07         0.0028     0.0396           Downregulated
  hsa-miR-6511a-5p              43.38            40.66           0.0029     0.0396           Downregulated
  hsa-miR-6724-5p               886.55           827.04          0.0027     0.0396           Downregulated
  hsa-miR-28-5p                 0.65             0.97            0.0030     0.0397           Upregulated
  hsa-miR-30b-5p                17.20            19.78           0.0030     0.0397           Upregulated
  ***RUNX1*** (rs8134179)^1^    TT (N=793)       TC/CC (N=317)                               
  hsa-miR-138-2-3p              6.29             7.08            0.0003     0.0469           Upregulated
  hsa-miR-3177-5p               4.23             4.85            0.0004     0.0469           Upregulated
  hsa-miR-3614-5p               4.96             5.95            \<.0001    0.0469           Upregulated
  hsa-miR-4461                  3.36             4.14            0.0003     0.0469           Upregulated
  hsa-miR-4519                  7.77             8.67            0.0003     0.0469           Upregulated
  hsa-miR-5696                  6.03             7.10            0.0004     0.0469           Upregulated
  hsa-miR-658                   0.64             0.80            0.0002     0.0469           Upregulated

^1^Data presented is restricted to those with the lowest adjusted p values. [Supplemental Table 1](#SD2){ref-type="supplementary-material"} contains all associations with FDR \<0.09.

Four SNPs, *RUNX2* rs12333172, *eIF4E* rs12498533, *BMPR1B* rs13134042, and *RUNX1* rs8134179 were associated predominately with increased miRNA expression in normal colonic mucosa for the variant allele. Six SNPs were associated with miRNA expression in normal rectal mucosa: *SMAD3* rs12904944, *TGFBR1* rs1571590, *eIF4EBP3* rs250425, *SMAD7* rs3736242, and *PTEN* rs532678, and *TGFBR1* rs6478974 (Table [3](#T3){ref-type="table"}). SNPs in *TGFBR1* were associated with expression of miRNAs for colorectal normal mucosa overall as well as for rectal normal mucosa specifically. *eIF4E* rs12498533 was associated with downregulation of miR-221-3p in overall colorectal mucosa and also was associated with upregulation of miR-3180-3p in normal colonic mucosa. *RUNX1* rs8134179 was associated with miR-658 in a similar manner for colorectal ([Supplemental Table 2](#SD2){ref-type="supplementary-material"} For all miRNAs associated with TGFBeta signaling pathway SNPs in normal colonic mucosa and [Supplemental Table 3](#SD2){ref-type="supplementary-material"} for associations in normal rectal mucosa) normal mucosa overall and colon-specific normal mucosa.

###### Associations between SNPs in TGFβ-signaling pathway and miRNA expression in site-specific normal mucosa

  Colon Tissue                                                                     
  ----------------------------- --------------- --------------- --------- -------- ---------------
  ***RUNX2*** (rs12333172)^1^   CC/CT (N=626)   TT (N=36)                          
  hsa-miR-1226-5p               54.59           79.49           0.0015    0.0717   Upregulated
  hsa-miR-26a-5p                82.50           64.46           0.0009    0.0717   Downregulated
  hsa-miR-30c-1-3p              11.15           15.53           0.0012    0.0717   Upregulated
  hsa-miR-3621                  37.96           53.40           0.0014    0.0717   Upregulated
  hsa-miR-3663-3p               167.22          252.07          0.0015    0.0717   Upregulated
  hsa-miR-3960                  10454.46        20170.24        0.0015    0.0717   Upregulated
  hsa-miR-4316                  6.93            4.87            0.0014    0.0717   Downregulated
  hsa-miR-4498                  63.88           56.98           0.0002    0.0717   Downregulated
  hsa-miR-4516                  17558.75        31136.08        0.0015    0.0717   Upregulated
  hsa-miR-4634                  326.83          612.64          0.0013    0.0717   Upregulated
  hsa-miR-4701-3p               75.06           109.36          0.0003    0.0717   Upregulated
  hsa-miR-4783-3p               16.70           23.43           0.0013    0.0717   Upregulated
  hsa-miR-5739                  1304.71         1856.95         0.0012    0.0717   Upregulated
  hsa-miR-628-3p                18.91           17.63           0.0010    0.0717   Downregulated
  hsa-miR-6723-5p               135.57          197.55          0.0009    0.0717   Upregulated
  hsa-miR-758-5p                32.86           30.14           0.0008    0.0717   Downregulated
  hsa-miR-921                   21.74           18.66           0.0012    0.0717   Downregulated
  ***EIF4E*** (rs12498533)      AA (N=188)      AC/CC (N=473)                      
  hsa-miR-3180-3p               16.08           18.65           \<.0001   0.0813   Upregulated
  ***BMPR1B*** (rs13134042)     GG/GA (N=640)   AA (N=22)                          
  hsa-miR-10a-3p                3.40            6.55            \<.0001   0.0813   Upregulated
  ***RUNX1*** (rs8134179)^1^    TT (N=463)      TC/CC (N=199)                      
  hsa-miR-526b-5p               3.52            4.13            \<.0001   0.0406   Upregulated
  hsa-miR-658                   0.72            0.95            \<.0001   0.0406   Upregulated
  hsa-miR-4659b-3p              3.77            4.78            0.0002    0.0542   Upregulated
  **Rectal Tissue**                                                                
  ***SMAD3*** (rs12904944)      GG (N=193)      GA/AA (N=255)                      
  hsa-miR-662                   38.47           42.35           \<.0001   0.0825   Upregulated
  ***TGFBR1*** (rs1571590)      AA (N=301)      AG/GG (N=147)                      
  hsa-miR-29b-3p                7.59            6.19            0.0002    0.0825   Downregulated
  hsa-miR-29c-3p                15.03           12.35           0.0002    0.0825   Downregulated
  ***EIF4EBP3*** (rs250425)     CC (N=288)      CT/TT (N=181)                      
  hsa-miR-4715-5p               1.79            2.68            \<.0001   0.0825   Upregulated
  ***SMAD7*** (rs3736242)       GG/GA (N=423)   AA (N=25)                          
  hsa-miR-431-5p                37.73           29.85           \<.0001   0.0825   Downregulated
  PTEN (rs532678)^1^            CC (N=167)      CT/TT (N=281)                      
  hsa-miR-10a-3p                2.55            1.86            0.0002    0.0450   Downregulated
  hsa-miR-1203                  2.03            1.55            0.0014    0.0450   Downregulated
  hsa-miR-1261                  3.26            2.61            0.0012    0.0450   Downregulated
  hsa-miR-130b-3p               3.22            2.47            0.0002    0.0450   Downregulated
  hsa-miR-1323                  3.74            2.91            0.0008    0.0450   Downregulated
  hsa-miR-138-2-3p              5.85            4.80            0.0018    0.0450   Downregulated
  hsa-miR-146b-5p               1.11            0.73            0.0008    0.0450   Downregulated
  hsa-miR-3617-5p               3.28            2.63            0.0012    0.0450   Downregulated
  hsa-miR-3660                  3.56            2.73            0.0003    0.0450   Downregulated
  hsa-miR-425-3p                13.76           16.55           0.0005    0.0450   Upregulated
  hsa-miR-4433-5p               18.04           20.40           0.0010    0.0450   Upregulated
  hsa-miR-4436a                 4.67            3.67            0.0005    0.0450   Downregulated
  hsa-miR-4436b-3p              6.46            5.40            0.0011    0.0450   Downregulated
  hsa-miR-4448                  8.25            7.07            0.0017    0.0450   Downregulated
  hsa-miR-4508                  51.88           57.14           0.0012    0.0450   Upregulated
  hsa-miR-452-5p                8.70            7.25            0.0009    0.0450   Downregulated
  hsa-miR-4657                  1.60            1.16            0.0018    0.0450   Downregulated
  hsa-miR-4665-3p               104.81          119.79          0.0012    0.0450   Upregulated
  hsa-miR-4682                  0.95            0.62            0.0018    0.0450   Downregulated
  hsa-miR-4746-5p               2.91            2.33            0.0013    0.0450   Downregulated
  hsa-miR-4748                  4.64            3.78            0.0006    0.0450   Downregulated
  hsa-miR-4787-3p               94.67           106.09          0.0003    0.0450   Upregulated
  hsa-miR-500a-3p               2.43            1.95            0.0007    0.0450   Downregulated
  hsa-miR-509-5p                7.57            6.81            0.0018    0.0450   Downregulated
  hsa-miR-516b-5p               5.41            4.24            \<.0001   0.0450   Downregulated
  hsa-miR-518a-5p               4.58            3.86            0.0013    0.0450   Downregulated
  hsa-miR-518c-5p               1.22            0.82            0.0014    0.0450   Downregulated
  hsa-miR-519e-5p               1.93            1.32            0.0006    0.0450   Downregulated
  hsa-miR-583                   3.31            2.54            0.0018    0.0450   Downregulated
  hsa-miR-629-3p                14.57           16.06           0.0015    0.0450   Upregulated
  hsa-miR-659-5p                1.58            0.98            0.0008    0.0450   Downregulated
  hsa-miR-766-3p                26.60           29.75           0.0017    0.0450   Upregulated
  hsa-miR-92a-1-5p              0.50            0.33            0.0015    0.0450   Downregulated
  ***TGFBR1*** (rs6478974)      TT (N=150)      TA/AA (N=298)                      
  hsa-miR-3917                  94.31           87.13           \<.0001   0.0825   Downregulated

^1^ Data presented is restricted to those with the lowest adjusted p values. [Supplementary Table 2 and 3](#SD2){ref-type="supplementary-material"} contain all associations with FDR \<0.09.

Differences in expression between carcinoma and normal mucosa, or differential miRNA expression by genotype, was associated with six SNPs, *SMAD3* rs12708492, *BMPR2* rs228545, and *NFκB1* rs230510, SMAD3 rs2414937, *NFκB1* rs3821958, *and RUNX3* rs6672420 (Table [4](#T4){ref-type="table"}) for colorectal cancer overall. *SMAD3* rs12708492 was associated with differential miRNA expression of six miRNAs miR-23a-5p, miR-30c-2-3p, miR-4286, miR-4753-5p, miR-4753-3p and miR-4679-5p by genotype. All miRNAs were downregulated with the variant allele except for miR-4286, where the expression was upregulated in the presence of the variant allele. *SMAD3* rs2414937 was associated with only one miRNA, miR-590-5p, and it was upregulated among those with the variant allele. *NFκB1* rs230510 was associated with expression of several miRNAs, all of which were downregulated for the variant allele, however the miRNAs associated with *NFκB1* rs3821958 were upregulated. Interestingly miR-4684-3p was upregulated in the variant allele of *NFκB1* rs230510 while downregulated in the presences of the variant allele of *NFκB1* rs3821958.

###### Associations with SNPs in TGFβ-signaling pathway and differential expression of colorectal carcinoma and normal mucosa

  miRNA                      Mean             Mean            P-value   FDR adjusted P   Direction
  -------------------------- ---------------- --------------- --------- ---------------- ---------------
  ***SMAD3*** (rs12708492)   CC (N=284)       CT/TT (N=778)                              
  hsa-miR-23a-5p             1.00             0.21            0.0002    0.0820           Downregulated
  hsa-miR-30c-2-3p           0.57             -0.20           0.0003    0.0820           Downregulated
  hsa-miR-4286               -198.94          -9.20           0.0005    0.0820           Upregulated
  hsa-miR-4753-5p            3.88             2.04            0.0003    0.0820           Downregulated
  hsa-miR-4755-3p            0.08             -1.16           0.0005    0.0820           Downregulated
  hsa-miR-4769-5p            2.51             1.45            0.0006    0.0820           Downregulated
  ***BMPR2*** (rs2228545)    GG (N=1001)      GA/AA (N=65)                               
  hsa-miR-484                -0.01            0.79            \<.0001   0.0820           Upregulated
  **NFKB1** (rs230510)       AA (N=369)       AT/TT (N=697)                              
  hsa-miR-3187-5p            1.37             0.63            \<.0001   0.0410           Downregulated
  hsa-miR-3617-5p            0.38             -0.41           \<.0001   0.0410           Downregulated
  hsa-miR-4684-3p            0.12             -0.32           0.0002    0.0410           Downregulated
  hsa-miR-6500-3p            0.44             -0.33           0.0002    0.0410           Downregulated
  hsa-miR-493-3p             0.34             -0.17           0.0003    0.0492           Downregulated
  hsa-miR-3189-5p            0.43             -0.34           0.0005    0.0586           Downregulated
  hsa-miR-596                -0.01            -0.43           0.0005    0.0586           Downregulated
  hsa-miR-4768-3p            -0.04            -0.68           0.0006    0.0615           Downregulated
  hsa-miR-4461               0.94             0.31            0.0007    0.0638           Downregulated
  hsa-miR-302c-5p            0.63             0.27            0.0008    0.0656           Downregulated
  hsa-miR-4296               0.62             0.31            0.0009    0.0671           Downregulated
  hsa-miR-4675               0.57             -0.22           0.0011    0.0752           Downregulated
  hsa-miR-4251               1.52             0.93            0.0013    0.0761           Downregulated
  hsa-miR-4458               -1.46            -2.15           0.0013    0.0761           Downregulated
  hsa-miR-1276               0.34             -0.07           0.0014    0.0765           Downregulated
  **SMAD3** (rs2414937)      GG/GC (N=1027)   CC (N=39)                                  
  hsa-miR-590-5p             -0.14            1.65            \<.0001   0.0820           Upregulated
  ***NFKB1*** (rs3821958)    AA (N=352)       AG/GG (N=714)                              
  hsa-miR-4282               -1.09            -0.30           \<.0001   0.0410           Upregulated
  hsa-miR-4684-3p            -0.51            0.00            \<.0001   0.0410           Upregulated
  hsa-miR-632                -0.51            0.13            0.0003    0.0820           Upregulated
  ***RUNX3*** (rs6672420)    AA (N=296)       AT/TT (N=770)                              
  hsa-miR-4261               1.38             0.51            \<.0001   0.0820           Downregulated

Four SNPs, *BMPR1B* rs12508087, *BMPR1B* rs2120834, *BMPR2* rs2228545, and e*IF4EBP3* rs250425 were associated with differences in differential miRNA expression for colon tissue (Table [5](#T5){ref-type="table"}). The majority of miRNAs associated with *BMPR1B* rs12508087 and rs2120834, and for *BMPR2* rs2228545 showed upregulated differential expression. [Supplemental Table 4](#SD2){ref-type="supplementary-material"} shows all miRNAs whose differential expression was associated with TGFBeta signaling pathway SNPs in colon tissue for the variant allele of e*IF4EBP3* rs250425 were downregulated.

###### Associations between SNPs in TGFB-signaling pathway and differential expression between colon carcinoma and normal mucosa

  miRNA                          Mean            Mean            P-values   FDR adjusted P   Direction
  ------------------------------ --------------- --------------- ---------- ---------------- ---------------
  ***BMPR1B*** (rs12508087)^1^   TT (N=378)      TA/AA (N=252)                               
  hsa-miR-1182                   0.29            3.37            0.0008     0.0165           Upregulated
  hsa-miR-1224-5p                -127.48         -16.55          0.0008     0.0165           Upregulated
  hsa-miR-1225-5p                -422.11         83.75           0.0009     0.0165           Upregulated
  hsa-miR-1228-3p                -2.66           2.94            0.0006     0.0165           Upregulated
  hsa-miR-1233-1-5p              -26.41          -7.97           0.0012     0.0165           Upregulated
  hsa-miR-1234-5p                -828.58         -28.93          0.0012     0.0165           Upregulated
  hsa-miR-1268b                  -24.76          179.09          0.0003     0.0165           Upregulated
  hsa-miR-138-2-3p               -0.75           -1.86           0.0002     0.0165           Downregulated
  hsa-miR-140-3p                 -1.45           -2.78           \<.0001    0.0165           Downregulated
  hsa-miR-146b-5p                1.07            0.36            0.0004     0.0165           Downregulated
  hsa-miR-150-3p                 -31.45          11.22           0.0007     0.0165           Upregulated
  hsa-miR-188-5p                 -76.36          2.88            0.0010     0.0165           Upregulated
  hsa-miR-1915-3p                -668.47         -162.98         0.0003     0.0165           Upregulated
  hsa-miR-194-3p                 -1.66           -0.88           0.0006     0.0165           Upregulated
  hsa-miR-2861                   -1203.17        -328.03         0.0002     0.0165           Upregulated
  hsa-miR-3141                   5.19            45.05           0.0011     0.0165           Upregulated
  hsa-miR-345-3p                 -1.80           7.61            0.0008     0.0165           Upregulated
  hsa-miR-3621                   -3.53           0.83            0.0011     0.0165           Upregulated
  hsa-miR-3648                   38.94           92.29           \<.0001    0.0165           Upregulated
  hsa-miR-3656                   -298.14         144.78          0.0004     0.0165           Upregulated
  hsa-miR-3665                   -590.36         -110.88         0.0004     0.0165           Upregulated
  hsa-miR-3940-5p                -127.51         -9.57           0.0008     0.0165           Upregulated
  hsa-miR-4298                   12.36           42.06           0.0009     0.0165           Upregulated
  hsa-miR-4322                   3.79            16.68           0.0003     0.0165           Upregulated
  hsa-miR-4433-3p                -32.27          34.14           0.0008     0.0165           Upregulated
  hsa-miR-4436a                  -0.07           -0.82           0.0010     0.0165           Downregulated
  hsa-miR-4463                   -20.48          28.51           0.0005     0.0165           Upregulated
  hsa-miR-4466                   -264.72         32.20           0.0012     0.0165           Upregulated
  hsa-miR-4507                   -330.49         -70.42          0.0006     0.0165           Upregulated
  hsa-miR-4508                   -10.99          -5.08           0.0011     0.0165           Upregulated
  hsa-miR-4640-5p                2.32            5.29            0.0005     0.0165           Upregulated
  hsa-miR-4687-3p                -435.67         -17.28          0.0006     0.0165           Upregulated
  hsa-miR-4688                   1.16            5.27            0.0004     0.0165           Upregulated
  hsa-miR-4690-5p                -54.41          -29.56          0.0010     0.0165           Upregulated
  hsa-miR-4701-3p                -0.09           7.90            0.0011     0.0165           Upregulated
  hsa-miR-4707-5p                -7.99           7.31            0.0006     0.0165           Upregulated
  hsa-miR-4710                   0.85            5.10            0.0011     0.0165           Upregulated
  hsa-miR-4741                   -91.90          96.96           0.0009     0.0165           Upregulated
  hsa-miR-483-5p                 3.36            25.50           0.0010     0.0165           Upregulated
  hsa-miR-487b                   0.04            -0.44           0.0011     0.0165           Downregulated
  hsa-miR-498                    -3.77           0.20            0.0008     0.0165           Upregulated
  hsa-miR-5196-5p                6.80            16.80           0.0006     0.0165           Upregulated
  hsa-miR-5585-3p                -7.93           25.37           0.0011     0.0165           Upregulated
  hsa-miR-572                    -95.60          -27.10          0.0007     0.0165           Upregulated
  hsa-miR-6068                   -507.73         -158.29         0.0005     0.0165           Upregulated
  hsa-miR-6069                   -1.29           2.00            0.0003     0.0165           Upregulated
  hsa-miR-6076                   -32.27          -1.35           0.0006     0.0165           Upregulated
  hsa-miR-6083                   -8.29           -4.69           0.0006     0.0165           Upregulated
  hsa-miR-6088                   -412.01         127.38          0.0012     0.0165           Upregulated
  hsa-miR-6089                   -5587.19        -1383.72        0.0010     0.0165           Upregulated
  hsa-miR-6165                   17.88           87.26           0.0008     0.0165           Upregulated
  hsa-miR-623                    -5.24           0.67            0.0010     0.0165           Upregulated
  hsa-miR-638                    -690.46         -126.32         0.0008     0.0165           Upregulated
  hsa-miR-6511a-5p               1.31            6.67            0.0003     0.0165           Upregulated
  hsa-miR-671-5p                 -49.00          2.17            0.0003     0.0165           Upregulated
  hsa-miR-6722-3p                -11.44          7.03            \<.0001    0.0165           Upregulated
  hsa-miR-6724-5p                -90.62          32.59           0.0012     0.0165           Upregulated
  hsa-miR-718                    -17.75          1.48            0.0004     0.0165           Upregulated
  hsa-miR-937-5p                 -43.41          42.52           0.0009     0.0165           Upregulated
  hsa-miR-3937                   -6.32           3.66            0.0013     0.0170           Upregulated
  hsa-miR-4734                   -24.78          -2.09           0.0013     0.0170           Upregulated
  hsa-miR-6073                   -1.63           -2.34           0.0013     0.0170           Downregulated
  ***BMPR1B*** (rs2120834)       GG/GC (N=545)   CC (N=85)                                   
  hsa-miR-4638-3p                -0.02           0.66            \<.0001    0.0813           Upregulated
  ***BMPR2*** (rs2228545)^1^     GG (N=598)      GA/AA (N=32)                                
  hsa-miR-3676-3p                0.06            3.22            \<.0001    0.0406           Upregulated
  hsa-miR-550a-5p                -0.86           1.65            \<.0001    0.0406           Upregulated
  ***EIF4EBP3*** (rs250425)^1^   CC (N=398)      CT/TT (N=235)                               
  hsa-let-7g-5p                  9.14            -2.75           0.0003     0.0406           Downregulated
  hsa-miR-103a-3p                21.18           9.39            0.0005     0.0406           Downregulated
  hsa-miR-141-3p                 13.30           3.76            0.0004     0.0406           Downregulated
  hsa-miR-15b-5p                 9.35            1.64            \<.0001    0.0406           Downregulated
  hsa-miR-16-5p                  16.07           -0.96           0.0004     0.0406           Downregulated
  hsa-miR-194-5p                 -20.67          -42.84          0.0004     0.0406           Downregulated
  hsa-miR-200c-3p                36.61           6.04            0.0003     0.0406           Downregulated
  hsa-miR-215                    -20.96          -33.34          0.0004     0.0406           Downregulated
  hsa-miR-30b-5p                 2.26            -2.26           0.0004     0.0406           Downregulated
  hsa-miR-92a-3p                 62.24           45.02           0.0005     0.0406           Downregulated
  hsa-miR-192-5p                 -32.40          -59.23          0.0007     0.0474           Downregulated
  hsa-miR-200a-3p                5.36            2.30            0.0007     0.0474           Downregulated
  hsa-miR-107                    13.80           6.52            0.0009     0.0488           Downregulated
  hsa-miR-20a-5p                 43.71           33.81           0.0009     0.0488           Downregulated
  hsa-miR-29a-3p                 58.54           37.06           0.0008     0.0488           Downregulated
  hsa-miR-200b-3p                33.13           3.61            0.0011     0.0497           Downregulated
  hsa-miR-27a-3p                 31.16           23.35           0.0010     0.0497           Downregulated
  hsa-miR-27b-3p                 8.79            3.34            0.0011     0.0497           Downregulated

^1^ Data presented limited to the most significant adjusted p values; [Supplementary Table 4](#SD2){ref-type="supplementary-material"} contains information for all associations with FDR \<0.09.

*SMAD3* rs12901071, rs1498506, and rs2414937 were associated with differential miRNA expression in rectal tissue; however, only one miRNA was dysregulated for both rs12901071 and rs2414937. MiR-17-5p was upregulated by *SMAD3* rs12901071 and downregulated by *SMAD3* rs2414937 (Table [6](#T6){ref-type="table"}). Additionally, *BMPR2* rs2228545 and *RUNX2* rs2819854 genotypes were associated with differential miRNA expression between rectal carcinoma and normal rectal mucosa. Both miR-324-5p and miR-484 were upregulated for the variant allele of *BMPR2* rs2228545 while all but two miRNAs were ([Supplemental Table 5](#SD2){ref-type="supplementary-material"} shows associations with TGFBeta signaling pathway SNPs for all differentially expressed miRNAs in rectal tissue) downregulated in the variant allele of *RUNX2* rs2819854.

###### Associations between SNPs in TGFB-signaling pathway and differential expression between paired rectal carcinoma and normal mucosa

  miRNA                         Mean            Mean            P-values   FDR adjusted P   Direction
  ----------------------------- --------------- --------------- ---------- ---------------- ---------------
  ***SMAD3*** (rs12901071)^1^   AA/AG (N=401)   GG (N=35)                                   
  hsa-miR-106b-5p               8.99            10.77           0.0062     0.0633           Downregulated
  hsa-miR-1202                  -87.93          -307.26         0.0050     0.0633           Downregulated
  hsa-miR-1207-5p               -271.79         -642.49         0.0037     0.0633           Downregulated
  hsa-miR-1224-5p               -108.00         -243.68         0.0038     0.0633           Downregulated
  hsa-miR-1226-5p               -3.96           -12.74          0.0049     0.0633           Downregulated
  hsa-miR-1229-3p               -7.12           -11.15          0.0021     0.0633           Downregulated
  hsa-miR-1233-1-5p             -26.35          -52.61          0.0061     0.0633           Downregulated
  hsa-miR-1249                  -1.87           -8.53           0.0023     0.0633           Downregulated
  hsa-miR-1273c                 -0.78           -5.34           0.0020     0.0633           Downregulated
  hsa-miR-134                   -35.39          -87.31          0.0011     0.0633           Downregulated
  hsa-miR-149-3p                -2.88           -7.98           0.0046     0.0633           Downregulated
  hsa-miR-17-5p                 40.01           46.53           0.0030     0.0633           Upregulated
  hsa-miR-188-5p                -52.14          -138.57         0.0026     0.0633           Downregulated
  hsa-miR-197-5p                -238.29         -716.04         0.0036     0.0633           Downregulated
  hsa-miR-19b-3p                17.46           20.65           0.0024     0.0633           Downregulated
  hsa-miR-20b-5p                12.23           14.48           0.0018     0.0633           Upregulated
  hsa-miR-26b-5p                0.16            2.92            0.0037     0.0633           Downregulated
  hsa-miR-2861                  -1175.18        -2275.40        0.0065     0.0633           Downregulated
  hsa-miR-29b-3p                11.43           16.18           0.0002     0.0633           Upregulated
  hsa-miR-29c-3p                1.32            5.20            0.0017     0.0633           Downregulated
  hsa-miR-3132                  -0.42           -4.66           0.0022     0.0633           Downregulated
  hsa-miR-3188                  -35.57          -68.70          0.0059     0.0633           Downregulated
  hsa-miR-3194-5p               -15.89          -43.87          0.0063     0.0633           Downregulated
  hsa-miR-3196                  -223.46         -396.40         0.0047     0.0633           Downregulated
  hsa-miR-3197                  -3.13           -7.12           0.0055     0.0633           Downregulated
  hsa-miR-34a-5p                8.57            11.04           0.0012     0.0633           Upregulated
  hsa-miR-3610                  -20.83          -45.81          0.0049     0.0633           Downregulated
  hsa-miR-3621                  -3.32           -8.78           0.0038     0.0633           Downregulated
  hsa-miR-3665                  -533.04         -1101.36        0.0066     0.0633           Downregulated
  hsa-miR-3682-3p               -1.62           -12.28          0.0063     0.0633           Downregulated
  hsa-miR-370                   2.70            -4.18           0.0021     0.0633           Downregulated
  hsa-miR-371a-5p               -7.65           -39.77          0.0021     0.0633           Downregulated
  hsa-miR-3917                  -3.25           -18.21          0.0045     0.0633           Downregulated
  hsa-miR-3925-5p               -4.64           -10.52          0.0064     0.0633           Downregulated
  hsa-miR-3934-3p               -2.65           -6.87           0.0007     0.0633           Downregulated
  hsa-miR-3945                  -7.76           -14.21          0.0056     0.0633           Downregulated
  hsa-miR-4253                  -2.64           -9.12           0.0009     0.0633           Downregulated
  hsa-miR-4270                  -20.58          -94.56          0.0042     0.0633           Downregulated
  hsa-miR-4314                  -3.87           -10.44          0.0057     0.0633           Downregulated
  hsa-miR-4419b                 -1.11           -4.38           0.0041     0.0633           Downregulated
  hsa-miR-4430                  -168.61         -399.75         0.0021     0.0633           Downregulated
  hsa-miR-4476                  -6.62           -16.39          0.0066     0.0633           Downregulated
  hsa-miR-4481                  -4.73           -16.10          0.0051     0.0633           Downregulated
  hsa-miR-4486                  -14.98          -50.49          0.0017     0.0633           Downregulated
  hsa-miR-4487                  -9.85           -25.84          0.0030     0.0633           Downregulated
  hsa-miR-4497                  -404.65         -1071.14        0.0006     0.0633           Downregulated
  hsa-miR-4508                  -11.27          -19.57          0.0058     0.0633           Downregulated
  hsa-miR-4513                  0.07            -3.34           0.0057     0.0633           Downregulated
  hsa-miR-4516                  -3221.62        -6327.76        0.0031     0.0633           Downregulated
  hsa-miR-4530                  -582.44         -2083.04        0.0007     0.0633           Downregulated
  hsa-miR-4535                  -5.24           -13.70          0.0043     0.0633           Downregulated
  hsa-miR-4632-5p               -18.74          -47.70          0.0037     0.0633           Downregulated
  hsa-miR-4646-5p               -2.94           -19.35          0.0042     0.0633           Downregulated
  hsa-miR-4655-5p               -0.88           -6.36           0.0013     0.0633           Downregulated
  hsa-miR-4656                  -2.80           -21.20          0.0044     0.0633           Downregulated
  hsa-miR-4665-5p               -3.35           -10.95          0.0030     0.0633           Downregulated
  hsa-miR-4695-5p               -40.01          -97.81          0.0015     0.0633           Downregulated
  hsa-miR-4721                  -158.17         -394.68         0.0031     0.0633           Downregulated
  hsa-miR-4734                  -26.33          -64.44          0.0019     0.0633           Downregulated
  hsa-miR-4739                  -150.29         -326.46         0.0008     0.0633           Downregulated
  hsa-miR-4740-5p               -1.84           -7.04           0.0022     0.0633           Downregulated
  hsa-miR-4741                  -61.75          -305.13         0.0028     0.0633           Downregulated
  hsa-miR-4745-5p               -36.68          -76.35          0.0024     0.0633           Downregulated
  hsa-miR-4758-5p               2.72            -16.93          0.0061     0.0633           Downregulated
  hsa-miR-4763-3p               -115.00         -347.06         0.0055     0.0633           Downregulated
  hsa-miR-4783-3p               -2.21           -5.03           0.0023     0.0633           Downregulated
  hsa-miR-4788                  -15.89          -64.61          0.0036     0.0633           Downregulated
  hsa-miR-5001-5p               -220.39         -447.83         0.0063     0.0633           Downregulated
  hsa-miR-5195-3p               -13.20          -40.01          0.0049     0.0633           Downregulated
  ***SMAD3*** (rs1498506)       AA (N=120)      AC/CC (N=316)                               
  hsa-miR-652-3p                0.05            0.63            \<.0001    0.0825           Upregulated
  ***BMPR2*** (rs2228545)       GG (N=403)      GA/AA (N=33)                                
  hsa-miR-324-5p                1.42            3.90            0.0002     0.0825           Upregulated
  hsa-miR-484                   0.06            1.57            \<.0001    0.0825           Upregulated
  ***SMAD3*** (rs2414937)^1^    GG/GC (N=418)   CC (N=18)                                   
  hsa-miR-1273g-3p              -791.41         -65.42          0.0006     0.0550           Upregulated
  hsa-miR-17-5p                 41.32           22.24           0.0003     0.0550           Downregulated
  hsa-miR-196b-5p               11.40           2.67            0.0003     0.0550           Downregulated
  hsa-miR-20a-5p                48.80           28.38           0.0005     0.0550           Downregulated
  hsa-miR-3651                  34.71           18.55           0.0006     0.0550           Downregulated
  hsa-miR-375                   -46.53          -24.12          0.0005     0.0550           Upregulated
  hsa-miR-4538                  -42.83          -10.65          0.0004     0.0550           Upregulated
  hsa-miR-4539                  -23.96          -5.29           \<.0001    0.0550           Upregulated
  hsa-miR-4697-5p               -19.48          13.48           0.0003     0.0550           Upregulated
  ***RUNX2*** (rs2819854)^1^    CC/CT (N=341)   TT (N=95)                                   
  hsa-miR-10b-5p                -2.34           1.92            0.0012     0.0715           Upregulated
  hsa-miR-1182                  1.20            -1.13           0.0008     0.0715           Downregulated
  hsa-miR-1281                  -9.98           -17.90          0.0013     0.0715           Downregulated
  hsa-miR-129-5p                -1.16           -2.30           0.0008     0.0715           Downregulated
  hsa-miR-3150b-5p              -3.63           -6.53           0.0013     0.0715           Upregulated
  hsa-miR-3648                  45.76           9.95            0.0009     0.0715           Downregulated
  hsa-miR-365a-5p               -0.28           -2.66           0.0006     0.0715           Downregulated
  hsa-miR-3911                  10.28           1.46            0.0008     0.0715           Downregulated
  hsa-miR-4665-3p               -20.84          -40.12          0.0012     0.0715           Downregulated
  hsa-miR-4767                  -2.92           -7.01           0.0009     0.0715           Downregulated
  hsa-miR-4769-3p               -2.33           -4.60           0.0009     0.0715           Downregulated
  hsa-miR-514b-5p               2.08            -1.03           0.0013     0.0715           Downregulated
  hsa-miR-5585-3p               5.26            -36.48          \<.0001    0.0715           Downregulated

^1^Data presented for most significant p values; [Supplementary Table 5](#SD2){ref-type="supplementary-material"} contains information for all associations with FDR \<0.09.

DISCUSSION {#s3}
==========

The TGF-β-signaling pathway is one of the most important pathways involved in colorectal cancer development \[[@R32]\]. The TGF-β signaling pathway is involved in maintaining normal cell growth in a non-tumor cellular environment; alternatively, it can promote invasion and metastasis in neoplastic cells \[[@R27]\]. It has been proposed that miRNAs can act as intermediaries in a TGFB-miRNA pathway that both mediates cell growth and promotes invasive behavior \[[@R28]\]. Our data lend support to this dual role of the TGF-β signaling pathway. Distinct SNPs and associated miRNA expression were observed for normal colorectal mucosa and for differential expression of miRNAs between carcinoma and normal mucosa. MiRNA expression in normal mucosa reflects a non-tumor environment and the role of the TGF-β signaling pathway in maintaining normal cell growth. However, when examining differential expression between carcinoma and normal mucosa, associations suggest that the miRNA expression is more related to tumor promotion and possible metastatic potential.

One set of SNPs and genes associated with expression of miRNAs in normal mucosa consist of *eIF4E* and *TGFB1* and their receptors. These SNPs were previously shown to be associated with colon and rectal cancer risk \[[@R4], [@R6], [@R7]\]. eIF4E is essential for ribosomal recruitment and the initiation of translation \[[@R33]\]; eIF4E binds eIF4A and eIF4G to form the eIF4F complex that binds target mRNAs. In this system, eIF4E appears to be key in the regulation of translation initiation, as it physically binds the mRNA and is the least abundant initiation factor \[[@R34]\]; the interface of these genes with miRNAs is supported given the role of miRNAs is post-transcriptional. It has a sole phosphorylation site that interacts with either eIF4G or non-phosphorylated 4E-BP1; the PI3-Akt-mTOR pathway phosphorylates 4E-BP1 so that it releases eIF4E, allowing binding to eIF4G \[[@R34]\]. Thus eIF4E is important in the convergence of the TGF-β and Akt pathways, and its dysregulation is believed to be an important downstream regulator of Akt\'s action in tumorigenesis \[[@R6]\]. In the canonical TGF-β pathway, activated TGF-β receptors phosphorylate the c-terminal serine residues of the transcription factors in two different branches of the pathway \[[@R35]\]. In one branch, BMPs, a pleiotropic group of growth factors, are activated and signal through Smads 1/5/8 which act as transcription factors \[[@R36]\]. In the other branch, Smad2 and Smad3 (p-Smad 2/3) form heterotrimeric complexes with Smad 4, which translocate into the nucleus and regulate target gene expression \[[@R37]\]. *PTEN* rs532678 was associated with miRNA regulation in normal rectal mucosa. *PTEN* has been shown previously to influence the TGFβ pathway through downregulation of miRNAs \[[@R30]\].

The second role of the TGF-β signaling pathway, which is associated with greater metastatic potential, includes SNPs in *BMPs*, *RUNX*, *SMAD3*, and *NFκB1*. In this current study, we show that some of our previously observed SNPs associated with survival, play a role in differential miRNA expression between normal mucosa, colon, and rectal carcinoma tissues. This suggests that the second role of the TGF-β signaling pathway, i.e. greater metastatic potential, may be at play. The miRNAs associated with SNPs in *SMAD3* and *RUNX* for differential expression were different from those associated with these SNPs in normal mucosa, further suggesting different mechanisms by which genes and corresponding pathways are being regulated. These genes have previously been shown to play various roles in phenotype aggression, angiogenesis, and metastasis. BMPs are pleiotropic growth factors, whose dysregulation has been shown to deregulate colonic stem cell renewal in mouse models, allowing for de novo crypt formation \[[@R36]\]. In addition to their contribution to tumor initiation, BMP dysregulation has also been shown to play a role in angiogenesis \[[@R38], [@R39]\]. *RUNX2*, has been associated with survival and aggressive phenotype in sarcoma \[[@R40]\]. Likewise, in colon cancer, *RUNX2* has been significantly associated with Dukes staging, liver metastasis, and ERβ status \[[@R41]\]. In mice models, *SMAD3* loss has been associated with mRNA expression of VEGF, MCP-1, and IL-6 in the choroid \[[@R42]\]. Similarly, in colon cancer these cytokines have been associated with the tumor microenvironment, including angiogenesis. Moreover, in drug resistant colorectal cancer cells 5-flourouracil (5-FU) can stimulate Smad3, which is believed to contribute to drug resistance \[[@R43]\]. We have previously shown that interferons, possibly through NF-kB signaling, are associated with colon and rectal cancer risk and survival \[[@R44]\]. It is possible that the diversity of mechanisms associated with these genes and SNPs is through their regulation of miRNAs, which in turn influence expression of hundreds of other genes and pathways.

We have previously reported that *SMAD3* was associated with survival in rectal cancer \[[@R3]\]. Of the *SMAD3* SNPs associated with differential miRNA expression by genotype, *SMAD3* rs12708492 and rs2414937 were previously shown to their influence on survival in rectal and colon tumors cancers \[[@R6]\]. Here we find that rs2414037 is associated with differential miRNA expression between normal mucosa, colon, and rectal carcinoma tissues overall as well as for rectal tumors specifically; suggesting that miRNA dysregulation may be responsible for some of our previously documented observations with regards to the TGF-β pathway and survival. *RUNX2* also has been found to be associated with colon and rectal cancer. We previously found *RUNX2*, particularly interactions between these SNPs in *RUNX2* and *SMAD3*, showed strong interaction to increase risk for rectal cancer, as well as prognostic implications \[[@R6]\].

As we have previously shown \[[@R4]\] several SNPs associated with genes in this pathway interact with each other and with lifestyle factors to alter risk of colorectal cancer. Thus, this is a complex pathway. In this study we have only examined the main effects of the SNPs on levels of miRNA expression, although it should be acknowledged that pathways are more complicated given the extensive interaction between SNPs and other genetic and lifestyle factors. Interpretation of results is also complicated by the difficulty in assessing functionality of specific miRNAs. Given that each miRNA can regulated 100s or even 1000s of genes, there is a general lack of specificity in determining functionality in any specific setting. It is hoped that over time, as more information on miRNAs become available, determining specific functionality will become more straightforward. Despite these limitations, we believe that the data presented is making strides in understanding how miRNAs work as well as how specific genes in the TGF-β-signaling pathway operate. The study represents a large collection of colon and rectal data with paired normal and carcinoma tissue. We used the Agilent platform that allowed us to examine almost 1000 miRNAs commonly expressed in colorectal tissue. The data obtained from this platform has been shown to have both high repeatability and validity in terms of comparisons with qPCR expression data. Because studies such as the one presented here are relatively few, we encourage others to conduct similar studies to build on and confirm our results.

In summary we have shown that genetic variation in the TGF-β-signaling pathway influences expression of miRNAs in colorectal tissue. While some genes and their related SNPs influenced miRNA expression in normal tissue, another set influences differential expression between carcinoma and normal mucosa. These results provide support for the functionality of these SNPs that previously have been associated with either colorectal cancer risk or survival, but also provide insight into how expression levels of miRNAs can be altered. The influence on miRNA expression by SNPs in the TGF-β-signaling pathway and the influence of miRNAs on 100s of targeted genes embody the diversity and importance of the TGF-β-signaling pathway in the carcinogenic process.

MATERIALS AND METHODS {#s4}
=====================

Study participants {#s4_1}
------------------

Study participants were recruited as part of two population-based case-control studies that included all incident colon and rectal cancer between 30 to 79 years of age who resided in Utah or were members of the Kaiser Permanente Medical Care Program (KPMCP) in Northern California. Participants were white, Hispanic, or black for the colon cancer study and also included participants of Asian race for the rectal portion of the study \[[@R45], [@R46]\]. Case diagnosis was verified by tumor registry data as a first primary adenocarcinoma of the colon and were diagnosed between October 1991 and September 1994 and for rectal were diagnosed between May 1997 and May 2001. Detailed study methods have been described \[[@R47]\]. The Institutional Review Boards of the University of Utah and at KPMCP approved the study. In this study we included 1188 participants for whom we have genotype and miRNA data.

miRNA processing {#s4_2}
----------------

Formalin-fixed paraffin embedded tissue from the initial biopsy or surgery was used to extract RNA. Carcinoma tissue and adjacent normal mucosa were used to make RNA. Cells were dissected from 1-4 sequential sections on aniline blue stained slides using an H&E slide for reference. Total RNA was extracted, isolated, and purified using the RecoverAll Total Nucleic Acid isolation kit (Ambion); RNA yields were determined using a NanoDrop spectrophotometer.

miRNA {#s4_3}
-----

The Agilent Human miRNA Microarray V19.0 was used due to the number of miRNAs, its high level of reliability (repeatability coefficient was 0.98 in our data), and the amount of RNA needed to run the platform. The microarray contains probes for 2006 unique human miRNAs as described previously. Data were required to pass stringent QC parameters established by Agilent that included tests for excessive background fluorescence, excessive variation among probe sequence replicates on the array, and measures of the total gene signal on the array to assess low signal. If samples failed to meet quality standards for any of these parameters, the sample was re-labeled, hybridized to arrays, and scanned again. If a sample failed QC assessment a second time, the sample was deemed to be of poor quality and the sample was excluded from analysis. Our previous analysis has shown that the repeatability associated with this microarray was extremely high (r=0.98) \[[@R47]\], and that comparison of miRNA expression levels obtained from the Agilent microarray to those obtained from qPCR had an agreement of 100% in terms of directionality of findings and that the fold change calculated for the miRNA expression difference between carcinoma and normal colonic mucosa was almost identical \[[@R48]\]. Of the 2006 unique human miRNAs assessed on the Agilent microarray, 1394 were expressed in colorectal tissue, 1226 in colorectal carcinoma tissue, and 1179 in normal colorectal mucosa. We further restricted the analysis to those miRNAs for which at least 20% of the population showed expression, leaving 820 miRNAs for colorectal cancer, 813 miRNAs for colon cancer, and 825 miRNAs for rectal cancer for analysis.

To normalize differences in miRNA expression that could be attributed to the array, amount of RNA, location on array, or factors that could erroneously influence miRNA expression levels, total gene signal was normalized by multiplying each sample by a scaling factor \[[@R49]\], which was the median of the 75^th^ percentiles of all the samples divided by the individual 75^th^ percentile of each sample.

TagSNP selection and genotyping {#s4_4}
-------------------------------

A customized GoldenGate chemistry (Illumina, San Diego, California) platform was assembled based on genes associated with the CHIEF (Convergence of Hormones, Inflammation, and Energy-related Factors) pathway \[[@R7], [@R26], [@R32], [@R50]\]. TagSNPs for genes in this pathway were selected using the following parameters: an r^2^=0.8 defined linkage disequilibrium (LD) blocks using a Caucasian LD map, minor allele frequency or minor allele frequency (MAF) \>0.1, range= -1500 bps from the initiation codon to +1500 bps from the termination codon, and 1 SNP/LD bin. A genotyping call rate of 99.85% was attained. Blinded internal replicates represented 4.4% of the sample set. The duplicate concordance rate was 100.00%. In this analysis we focused on 21 genes, *BMP1*, *BMP2*, *BMP4*, *BMPR1A*, *BMPR1B*, *BMPR2*, e*IF4E*, *eIF4EBP3*, *GDF10*, *MAPK1*, *MTOR*, *NFκB1*, *PTEN*, *RUNX1*, *RUNX2*, *RUNX3*, *SMAD2*, *SMAD3*, *SMAD4*, *SMAD7*, *TGFB1*, and *TGFBR1*.

Statistical methods {#s4_5}
-------------------

We assessed 80 SNPs in 21 genes that we previously have shown to be associated with colon or rectal cancer risk \[[@R3], [@R6], [@R7], [@R26], [@R32], [@R51]\] in 1188 individuals who also have miRNA expression in normal mucosa and 1141 who have both carcinoma and normal mucosa miRNA expression. Online [Supplemental Table 6](#SD1){ref-type="supplementary-material"} show all SNPs assessed. Analyses were run separately for colon and rectal cancer as well as for colorectal cancer combined. Log base 2 transformed miRNA expression level data were used to determine if miRNA expression levels were significantly different by genotype for each SNP. For the SNPs assessed, we used either a dominant or recessive model of inheritance based on previous reports (See [Supplementary Table 7](#SD2){ref-type="supplementary-material"}). To determine statistical significance, we fit a least-squares linear regression model to the miRNA expression levels and SNPs, adjusting for age at diagnosis, sex, and race/ethnicity. P-values were generated using the bootstrap method by creating a distribution of 10,000 F statistics derived by resampling the residuals from the null hypothesis of no association between the SNPs and the miRNA (Davison and Hinkley reference), using the 'boot' package in R. Associations were considered important if the false discovery rate (FDR) was less than 0.09 as described by Benjamini and Hochberg \[[@R52]\]; these associations had q-values less than 0.05 \[[@R53]\]. We present those most significant in the text and attach online supplements for those with a FDR of less than 0.09 ([Supplementary Tables 1, 2, 3, 4, 5](#SD2){ref-type="supplementary-material"}). Analyses were run for colorectal normal mucosa (Table [2](#T2){ref-type="table"}) as well as for unique association in normal mucosa by sub-site of the tissue, i.e. colon or rectal (Table [3](#T3){ref-type="table"}). Similar analysis were run for differential expression (carcinoma -- normal) for colorectal cancer overall (Table [4](#T4){ref-type="table"}) and for colorectal sub-site (Table [5](#T5){ref-type="table"} for colon and Table [6](#T6){ref-type="table"} for rectal).
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